Free Trial

61,291 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Doximity logo with Medical background

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 61,291 shares of the company's stock, valued at approximately $3,557,000.

A number of other institutional investors have also modified their holdings of the stock. LPL Financial LLC raised its stake in Doximity by 5.5% during the fourth quarter. LPL Financial LLC now owns 75,757 shares of the company's stock worth $4,045,000 after acquiring an additional 3,967 shares during the period. Vanguard Group Inc. raised its stake in Doximity by 4.5% during the fourth quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock worth $598,159,000 after acquiring an additional 485,102 shares during the period. Norges Bank acquired a new stake in Doximity during the fourth quarter worth about $4,368,000. New Age Alpha Advisors LLC acquired a new stake in Doximity during the fourth quarter worth about $485,000. Finally, Pictet Asset Management Holding SA raised its stake in Doximity by 547.0% during the fourth quarter. Pictet Asset Management Holding SA now owns 106,727 shares of the company's stock worth $5,698,000 after acquiring an additional 90,232 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. William Blair reiterated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Raymond James Financial dropped their price objective on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Morgan Stanley decreased their target price on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. JPMorgan Chase & Co. decreased their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research report on Tuesday, May 27th. Finally, The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a "neutral" rating in a research report on Wednesday, May 21st. Ten investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $64.89.

Get Our Latest Report on DOCS

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, July 11th. The shares were sold at an average price of $60.04, for a total transaction of $300,200.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at approximately $997,744.72. This trade represents a 23.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the sale, the director owned 6,360 shares of the company's stock, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 29,000 shares of company stock worth $1,711,760. Corporate insiders own 37.40% of the company's stock.

Doximity Price Performance

Shares of Doximity stock traded down $1.23 on Friday, hitting $57.52. The company had a trading volume of 496,955 shares, compared to its average volume of 2,345,273. The business has a 50-day simple moving average of $58.26 and a 200-day simple moving average of $59.74. The company has a market cap of $10.80 billion, a PE ratio of 57.50, a PEG ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.25 earnings per share. On average, equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines